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Abstract
Background: Epigenetic dysregulation is involved in the etiology and progression of various human diseases.
Formalin-fixed paraffin-embedded (FFPE) samples represent the gold standard for archiving pathology samples, and
thus FFPE samples are a major resource of samples in clinical research. However, chromatin-based epigenetic assays
in the clinical settings are limited to fresh or frozen samples, and are hampered by low chromatin yield in FFPE samples
due to the lack of a reliable and efficient chromatin preparation method. Here, we introduce a new chromatin extraction
method from FFPE tissues (Chrom-EX PE) for chromatin-based epigenetic assays.
Results: During rehydration of FFPE tissues, applying a tissue-level cross-link reversal into the deparaffinized tissue at 65 °C
dramatically increased chromatin yield in the soluble fraction. The resulting chromatin is compatible with targeted ChIP-
qPCR and genome-wide ChIP-seq approaches. The chromatin prepared by Chrom-EX PE showed a gradual
fragmentation pattern with varying incubation temperature. At temperatures below 37 °C, the majority of
soluble chromatin is over 1 kb. The soluble chromatin prepared in the range of 45–60 °C showed a typical
nucleosomal pattern. And the majority of chromatin prepared at 65 °C is close to mononucleosomal size.
These observations indicate that chromatin preparation from FFPE samples can be controlled for downstream
chromatin-based epigenetic assays.
Conclusions: This study provided a new method that achieves efficient extraction of high-quality chromatin
suitable for chromatin-based epigenetic assays with less damage on chromatin. This approach may provide a
way to circumvent the over-fixed nature of FFPE tissues for future technology development.
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Background
Epigenetic alterations have been well described in the
pathogenesis of various human diseases [1–3]. In com-
bination with next-generation sequencing technologies,
genome-wide epigenetic profiling has provided an un-
precedented opportunity to understand the regulatory
mechanisms underlying genome activities in disease eti-
ology and progression [3]. Epigenetic methodologies are
well established in cultured cells but are still limited in
clinical samples. FFPE samples are the gold standard for
archiving patient samples and have been utilized in the
diagnosis and clinical management of the vast majority of
diseases [4]. While FFPE methods include treatment with
formaldehyde, it is often applied at a higher concentration
of formalin and for a longer time to ensure proper and
longer preservation of the relatively large pieces of tissue
samples for downstream applications such as immunohis-
tochemistry. In these cases, FFPE samples may be heavily
over-fixed (i.e., more heavily cross-linked), which makes it
challenging to obtain chromatin with high yield for com-
mon epigenetic assays like chromatin immunoprecipita-
tion (ChIP) or other chromatin-based assays including
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chromatin accessibility, nucleosome positioning, and
chromatin-chromatin interaction. Over-fixation in FFPE
samples interferes with chromatin analysis in different
ways. First, over-fixation necessitates the use of harsher
chromatin fragmentation methods which, in turn, dam-
ages the chromatin. Harsher chromatin isolation ap-
proaches may increase the chromatin yield marginally, but
these small gains are usually negated by loss of chromatin
integrity. Second, over-fixation may manifest in random
crosslinking of chromatin with other cellular components
resulting in low signal-to-noise ratio and very low chro-
matin yields. There have been some advances in chroma-
tin extraction methods for FFPE samples [5–7], but a
reliable and efficient chromatin preparation method is still
needed.
The basic repeating unit of chromatin is nucleosome,
and it is associated with proteins and RNAs. Nucleosomes
and chromatin include epigenetic information such as
DNA-based epigenetic marks, histone tail modifications,
association with transcription factors or chromatin pro-
teins or regulatory RNAs, nucleosome positioning, acces-
sibility, and chromatin-chromatin interaction. While
chromatin-based epigenetic assays are feasible in FFPE tis-
sues [5–9], the detailed profiles of extracted chromatin are
limited and not well demonstrated. The first chromatin
extraction method from FFPE tissues called pathology
tissue-ChIP (PAT-ChIP) was established and validated for
ChIP assay using a combination of micrococcal nuclease
(MNase) digestion and extensive sonication in the pres-
ence of high concentration of SDS [5]. Another chromatin
extraction method called fixed-tissue chromatin immuno-
precipitation sequencing (FiT-seq) was developed by
introducing 1 h heating at 40 °C, proteinase K treatment,
and extensive sonication to improve chromatin extraction
[6]. The chromatin isolated from FiT-seq approach was
validated for ChIP assay but the information about chro-
matin yield and the sizes of extracted chromatin were not
assessed. In addition to the ChIP assay, one group demon-
strated the feasibility of chromatin accessibility assay in
FFPE tissues using DNase-seq [10]. Currently, nucleosome
positioning assay [11] and the methodologies dependent
on chromatin integrity such as chromatin interaction as-
says [12] are not applicable to FFPE tissues. We hypothe-
sized that regaining chromatin integrity close to intact or
at least recovering it partially by reducing cross-links be-
fore chromatin extraction may be beneficial to achieve
better chromatin yield and quality to overcome heavily
cross-linked nature of FFPE tissues.
In this study, we introduced a novel chromatin extrac-
tion method from FFPE tissues called Chrom-EX PE
technology to increase soluble chromatin yield with the
possibility of controlled preparation of chromatin from
FFPE tissues. This approach includes a tissue-level,
cross-link reversal step applied to deparaffinized tissue
to overcome the disadvantages of over-fixed chromatin.
We achieved approximately 70–90% soluble chromatin
yields from mouse FFPE tissues, and the isolated chroma-
tin was compatible with ChIP-seq for histone mark and
chromatin-associated protein. Furthermore, the chromatin
prepared by Chrom-EX PE showed a gradual fragmenta-
tion pattern with varying incubation temperatures. We be-
lieve this approach can be used to obtain high quality
chromatin for ChIP-seq without exposing the sample to
harsh treatment, and is potentially applicable to technol-
ogy development for other chromatin-based epigenetic
assays.
Results
Tissue-level cross-link reversal dramatically increases
soluble chromatin from FFPE tissues
The major challenge for chromatin extraction from FFPE
tissues is low chromatin yield due to high cross-linking
level of the tissue sample during preparation and long
storage time of FFPE samples. We hypothesized reducing
cross-linking before chromatin preparation would in-
crease chromatin yield from FFPE tissues. To test this hy-
pothesis, we introduced a tissue-level cross-link reversal
step by heating before chromatin preparation called
Chrom-EXPE (Fig. 1a). As incubation of cross-linked
chromatin at 65 °C is routinely utilized in ChIP assay, we
first tested tissue-level cross-link reversal with overnight
incubation at 65 °C. As a control and for comparison, we
tested a commercial kit (Active Motif) for chromatin ex-
traction from FFPE tissues following the manufacturer’s
instructions. After tissue-level cross-link reversal, MNase
digestion and sonication was utilized to extract chromatin.
Notably, the insoluble pellet after centrifugation is much
smaller with samples processed with tissue-level cross-link
reversal compared with the samples processed with the
commercial kit or without overnight incubation. The sol-
uble chromatin yield was calculated from purified DNA
from soluble and insoluble pellet fractions after extensive
cross-link reversal as described in conventional ChIP pro-
tocols. Surprisingly, tissue-level cross-link reversal dramat-
ically increased chromatin yield in FFPE samples from
mouse spleen, kidney, and liver (Fig. 1b). The soluble
chromatin yields achieved 71.6, 85.4 and 90.2% for liver,
kidney, and spleen, respectively, by Chrom-EX PE, while
the soluble chromatin yields reached 1.15, 6.48 and 2.54%
with the Active Motif commercial kit and 6.37, 15.45,
10.95% without 65 °C incubation for the same tissues.
These results demonstrate that Chrom-EX PE increases
the effectiveness of chromatin preparation from FFPE
samples and can achieve chromatin yields up to 90% of
the yields typically obtained using conventional techniques
from fresh or frozen tissues.
To further investigate chromatin yields in various in-
cubation temperatures, we performed the experiment
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at four different temperatures (25 °C, 45 °C, 55 °C, and
65 °C) using FFPE samples from liver tissue. To accur-
ately measure the impacts of incubation temperature
on chromatin yield, we isolated the chromatin by sonic-
ation but no MNase treatment after tissue-level
cross-linking reversal. The yield of soluble chromatin
gradually increases with temperature in 45 – 65 °C
range compared with the yield from room temperature
(Additional file 1), suggesting different level of
cross-linking reversal contributes to the increase of sol-
uble chromatin.
Chrom-EX PE enables chromatin to be prepared in a
controlled manner
We checked chromatin patterns generated in different
incubation temperatures for tissue-level cross-link rever-
sal. Chromatin was prepared from mouse liver FFPE tis-
sues by Chrom-EX PE in the range of 25 to 75 °C, and
DNA was purified from the resulting soluble chromatin
and analyzed by the Fragment Analyzer (Fig. 1c). In gen-
eral, low temperatures generated larger DNA fragments
over 1 kb and DNA sizes gradually decreased to around
mononucleosomal size with the increasing incubation
a b
c d
Fig. 1 A tissue-level cross-link reversal allows efficient extraction of high-quality chromatin from FFPE tissues. a Schematic diagram of chromatin
extraction method from FFPE tissues (ChromEX-PE). A tissue-level, cross-link reversal was introduced by incubating deparaffinized tissue in the
range of temperature from 25 to 75 °C before chromatin extraction. b Chrom-EX PE dramatically increases soluble chromatin from FFPE tissues.
Chromatin was prepared by Chrom-EX PE with 65 °C overnight incubation or without incubation. A commercial kit from Active motif was used as
control and for comparison. DNAs were purified from soluble fraction and insoluble pellet fraction and were quantified using Qubit dsDNA High
Sensitivity assay. The percentage of soluble chromatin was calculated from mouse spleen, kidney, and liver FFPE tissues. The data were generated
from two independent experiments. c Chrom-EX PE generates different sizes of chromatin in a controlled manner. Chromatin was prepared from
mouse liver FFPE tissues by Chrom-EX PE in the range of temperatures from 25 °C to 75 °C. Deparaffinized tissue was incubated in the indicated
temperature overnight in the chromatin stabilization buffer. In the range of 25–37 °C, a majority of soluble chromatin is larger than 1 kb. The
temperature ranges (45–55 °C) produce nucleosomal DNA patterns. The majority of DNA was mononucleosomal DNA at 60 °C incubation and
DNA size is closer or smaller than mononucleosomal DNA with temperature above 60 °C. d Chromatin yield by Chrom-EX PE from various mouse
tissues. The tissue volume is measured in FFPE block and two 20-μm sections were processed by Chrom-EX PE at 65 °C condition with chromatin
stabilization buffer. The DNA amount purified from soluble fraction was measured and the yield was calculated per tissue volume
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temperatures. In the range of 25–37 °C, a majority of
soluble chromatin is larger than 1 kb and a very small
fraction of DNA fragments around 50–100 bp. The
temperature range of 45–55 °C produced a nucleosomal
DNA profile that is typically observed when frozen tis-
sues and cell lines are treated with MNase. The majority
of DNA was mononucleosomal size in the range of 60–
65 °C, and DNA size is smaller than mononucleosomal
DNA at 75 °C. These observations indicated that
Chrom-EX PE is able to prepare chromatin in a con-
trolled manner from FFPE tissues. It is noteworthy
that the sizes of most soluble chromatin in the range
of 45–65 °C are about 100–500 bp, further increasing
usable chromatin in the assays and well suited for the
requirement of next-generation sequencing library
preparation for genome-wide chromatin-based epigen-
etic assays.
Chromatin yields from mouse FFPE tissues by Chrom-EX PE
The overall experimental quality of chromatin-based epi-
genetic assays is typically dependent on the total cellularity
but not the weight of tissue sample. As tissues show differ-
ent cellularity, we next sought to address chromatin yield
from different FFPE tissues by Chrom-EX PE in the opti-
mized chromatin stabilization buffer. The tissue volume is
measured in the FFPE block, and two 20 μm sections were
processed by Chrom-EX PE at 65 °C condition. The DNA
amount purified from soluble fraction was measured and
the yield was calculated (Fig. 1d).
Chromatin generated by Chrom-EX PE is compatible with
ChIP assays
To investigate whether the chromatin generated by
Chrom-EX PE is compatible with chromatin-based epigen-
etic assays, we elected to use chromatin immunoprecipita-
tion assay, which is the most often used methodology in
chromatin-based epigenetic analyses. The chromatin pre-
pared by Chrom-EX PE at 65 °C from four different mouse
liver FFPE tissue was incubated with anti-H3K4me3 or
anti-H3K27me3 antibodies and further processed following
published methods [13, 14]. The ChIP products were ana-
lyzed by real-time PCR in a transcriptionally active region
(GAPDH-TSS, positive for H3K4me3), in a developmen-
tally repressed region (T-TSS, positive for H3K27me3), and
in an intergenic region (negative for both H3K4me3 and
H3K27me3) (Fig. 2a and Additional file 2). The enrichment
of H3K4me3 mark is observed only in transcriptionally ac-
tive TSS, and H3K27me3 mark is observed only in develop-
mentally repressed locus in all four FFPE tissues. The DNA
size of chromatin input from 4 FFPE samples is in the
range of 100–200 bp without DNAs larger than 1 kb
(Additional file 3), consistent with the previous observation
(Fig. 1c) and showing consistency of the Chrom-EX PE ap-
proach. These results demonstrate that the chromatin
prepared from FFPE tissues using Chrom-EXPE is compat-
ible with a targeted ChIP-qPCR approach. Next, we further
investigated the compatibility of Chrom-EX PE with
next-generation sequencing library preparation for
genome-wide ChIP-seq. The chromatin input isolated by
Chrom-EX PE from mouse liver FFPE tissue was subjected
to ChIP for histone marks (H3K27Ac and H3K4me3,
H3K27me3) and a chromatin-associated protein (RNA
Polymerase II, Pol II). To compare the performance of
Chrom-EX PE, we also generated ChIP-seq data from fro-
zen tissues originating from the same mouse using pub-
lished ChIP-seq protocol [13, 14]. To evaluate the
reproducibility of Chrom-EX PE, we performed the experi-
ment in two replicates. The purified ChIP DNA was sub-
jected to library preparation as published [13] and the
library DNAs were analyzed by the Fragment Analyzer
(Additional file 4). The libraries were sequenced on Illu-
mina HiSeq 2000 platform. Peaks were called using the
MACS2 algorithm [15] for H3K4me3 and H3K27Ac and
SICER [16] for H3K27me3 and RNA Pol II at FDR < =1%.
The difference of overall enrichment is variable in sample
types per mark (Additional file 5). However, peak patterns
visualized in the Integrative Genome Viewer [17, 18] were
highly similar among the datasets from FFPE liver tissue by
Chrom-EX PE and those from frozen liver tissues by pub-
lished ChIP-seq protocol (Fig. 2b). As expected [19, 20],
H3K4me3 and H3K27Ac peaks are primarily located at
TSS of active genes, whereas H3K27me3 peaks are distrib-
uted over PRC2-repressed genes such as MYT1. These re-
sults strongly suggest that the chromatin generated by
Chrom-EX PE technology is compatible with ChIP-seq
approach.
Highly correlated and consistent ChIP-seq data are
generated from FFPE tissue by Chrom-EX PE
The ChIP-seq data for each mark was generated from two
20-μm FFPE-tissue sections from mouse liver and spleen
using Chrom-EX PE technology. To compare the per-
formance of Chrom-EX PE, we also generated ChIP-seq
data from frozen tissues originating from the same mouse.
The mapping details of all ChIP-seq libraries are summa-
rized (Additional file 6) [21]. In general, we did not ob-
serve clear differences in % uniquely mapped pairs, library
complexity, and % duplicates between libraries generated
from FFPE and frozen tissues. Some libraries generated by
Chrom-EX PE showed higher % duplicate, low complex-
ity, and low % unique pairs but other libraries generated
in the independent experiment showed the expected range
of QC results. We believe higher % duplicate, low com-
plexity, and low % unique pairs in some of ChIP-seq data
observed in FFPE samples is caused by over-amplification
of the library [22] but not by Chrom-EX PE technology.
Importantly, the total peak numbers for these libraries still
achieve the requirement for the data analysis.
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To investigate the experimental consistency of Chrom-EX
PE technology, we performed Pearson correlation analysis
between the datasets generated by Chrom-EX PE from ex-
perimental replicates. We observed uniformly high correl-
ation for three histone marks with Pearson correlation
coefficients ranging between 0.898 and 0.991 (p < 0.001)
(Fig. 3a). The detailed peak numbers and overlapping rate
in experimental replicates are shown for FFPE samples
(Table 1) and for frozen tissues (Additional file 7). We cal-
culated the overlap rate based on the dataset with fewer
peaks to investigate how many peaks are observed in the
same locations in two replicates. For H3K27Ac mark, about
92,000 peaks were detected with 91% overlap rate in re-
peats. About 48,000 peaks were detected with 84% overlap
rate for H3K4me3 mark and about 20,000 peaks were de-
tected with 64% overlap for H3K27me3 mark. These results
indicate that ChIP-seq data generated by Chrom-EX PE is
highly reproducible and consistent.
We further investigated whether ChIP-seq dataset gen-
erated by Chrom-EX PE is comparable with datasets gen-
erated from frozen tissues using a published ChIP-seq
protocol. Pearson correlation analysis show uniformly
high correlation for three histone marks between datasets
generated from FFPE tissues and frozen tissues obtained
from liver (Fig. 3b) and spleen (Fig. 3c). Pearson correl-
ation coefficients range between 0.898 and 0.967 (p <
0.001) in liver tissue and between 0.840 and 0.894 (p <
0.001) in spleen tissue. The detailed peak numbers and
overlap rate in FFPE and frozen tissues are shown in
Table 2. In general, the overall peak number detected is
comparable and overlap rate of peak is in the range of 61–
82% in the liver tissue and in the range of 82–95% in the
spleen tissue. For example, 128,000 H3K27Ac peaks were
detected from FFPE liver tissue by Chrom-EX PE and
113,000 peaks were detected from frozen liver tissue with
71% overlap rate. 56,000 H3K4me3 peaks were detected
a
b
Fig. 2 The chromatin generated by Chrom-EX PE is compatible with ChIP-qPCR and ChIP-seq. a The chromatin generated by Chrom-EX PE
produced consistent and high enrichment in ChIP-qPCR approach. Two 20-μm sections from mouse liver FFPE tissues were processed by Chrom-
EX PE at 65 °C condition. The resulting chromatin was immunoprecipitated as described in the Materials and Methods. ChIP DNAs were analyzed
by qPCR and enrichment in the tested loci is shown as the percentage of input. Four individual mouse FFPE liver tissues were used in
experiment. The genomic location of each primer pair along with peak profile of H3K4me3 and H3K27me3 marks are shown in the Additional file 3. b
Chromatin generated by Chrom-EX PE produced comparable ChIP-seq peaks with the results from frozen tissues. ChIP-seq experiment was performed
in the chromatin generated by Chrom-EX PE at 65 °C condition from two 20-μm sections of mouse liver FFPE tissues. As controls, ChIP-seq data was
generated from frozen tissues as described in the Materials and Methods. Snapshot image are shown for 3 histone marks (H3K27ac, K27 ac; H3K4me3,
K4me3; H3K27me3, K27me3) and RNA polymerase II (Pol II). ChIP-seq results were visualized in a 218 kb genomic region using the Integrative
Genomics Viewer [17, 18]. FFPE 1 and Frozen are the pair originated from the same mouse
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from FFPE liver tissue and 49,000 peaks were detected
from frozen liver tissue with 61% overlap rate. 19,000
H3K27me3 peaks were detected from FFPE liver tissues
and 30,000 peaks were detected from frozen liver tissue
with 82% overlap rate. These results indicate a high degree
of similarity among ChIP-seq dataset generated from






Fig. 3 Highly correlated genome-wide ChIP-seq data are generated from mouse FFPE tissues by Chrom-EX PE. a Scatter plots showing the
correlation between ChIP-seq datasets generated from the indicated repeats for FFPE liver tissue with H3K27Ac, H3K4me3 and H3K27me3 marks.
The genome was divided into bins of 5 kb for H3K4me3 and H3K27Ac marks and 100 kb for H3K27me3 mark, and the number of mapped reads
in the individual bins was calculated. r, Pearson correlation coefficient. b Scatter plots showing the correlation between ChIP-seq datasets
generated from FFPE liver tissue by Chrom-EX PE and the corresponding frozen liver tissues by conventional ChIP-seq for H3K27Ac, H3K4me3
and H3K27me3 marks. c Scatter plots showing the correlation between ChIP-seq datasets generated from a pair of mouse spleen tissues. d
Scatter plots showing the correlation between ChIP-seq datasets generated from FFPE liver tissue by Chrom-EX PE and the corresponding frozen
liver tissues by conventional ChIP-seq for RNA polymerase II
Table 1 Peak numbers and overlap rate of peaks from
experimental repeats from FFPE samples
Mark Total Peaks 1 Total Peaks 2 % Overlap
H3K27ac 128,624 92,165 90.91%
H3K4me3 56,688 48,129 83.90%
H3K27me3 19,765 23,234 64.14%
Zhong et al. BMC Genomics          (2019) 20:249 Page 6 of 11
To determine whether Chrom-EX PE technology is
applicable to large and non-histone protein or chromatin
complexes, we performed ChIP-seq for RNA polymerase
II (RNAP II) in two pairs of FFPE and frozen mouse
liver tissues. As expected, RNA Pol II peaks shown in
the IGV browser overlap with H3K4me3 marks in TSSs
of actively transcribed genes (Fig. 2b), and peak patterns
are similar among the datasets generated from FFPE and
frozen liver tissues. Pearson correlation coefficients
range from 0.930 to 0.945 (p < 0.001) in matched sample
pairs (Fig. 3d). The detailed peak numbers and overlap-
ping rate in match pairs are shown in Table 2. About
12,000 and 16,000 RNA Pol II peaks were detected in
two different FFPE tissues. These results indicate that
Chrom-EX PE is applicable to at least some non-histone
protein or chromatin complex in archived FFPE tissues.
Discussion
Fixation of cells by formaldehyde was introduced in the
ChIP assay to increase the stability of interactions in
chromatin by making covalent bonds between neighbor-
ing amino groups. Consequently, the solubility of chro-
matin is much lower in fixed cells compared with
unfixed cells. Over-fixation in FFPE tissues is believed to
be detrimental to chromatin extraction due to the nature
of heavily cross-linked chromatin. Harsh sonication was
typically introduced to overcome low solubility but this
introduces adverse damage in chromatin. We introduced
a tissue-level cross-linking reversal before chromatin
preparation called Chrom-EX PE. This approach dra-
matically increases soluble chromatin from FFPE tissue
and allows us to produce various degrees of chromatin
showing a gradual shift from partial, nucleosomal pat-
tern, to smaller than a mononucleosome after MNase di-
gestion and sonication. We validated here that the
chromatin generated by Chrom-EX PE at 65 °C is com-
patible with the ChIP assay. The chromatin generated in
the range of 45–55 °C showed a nucleosomal pattern
that is typically produced from frozen tissues and cell
lines, and may be compatible with nucleosome position-
ing along with ChIP assay (Fig. 1c). Partial digestion
patterns at lower temperatures may be compatible with
mapping of chromatin accessibility. Further research is
required to investigate whether Chrom-EX PE technol-
ogy is applicable to nucleosome positioning, chromatin
accessibility, or chromatin-chromatin interaction assays.
Based on chromatin yield and fragmentation pattern,
we believe that incubation of FFPE tissue in chromatin
stability buffer will cause decross-linking of covalent
bonds and the kinetics of decross-linking is dependent
on temperature and time. In the range of incubation
temperatures around 37–55 °C, decross-linking reaction
may be slow but more closely recover the original chro-
matin structure. At higher temperature, the reaction
may be faster and more effective. Published chromatin
preparation methods [6–8] support this hypothesis.
FiT-seq incubated FFPE samples at 40 °C for 1 h in 0.1%
SDS buffer [6]. We did not test 40 °C in this study but
40 °C may induce some degree of cross-link reversal and
subsequently increase soluble chromatin yield. With the
report of DNase-seq in FFPE samples [10], we noticed
that DNase I treatment was applied after incubation of
deparaffinized tissues in 37 °C for 2 h for FFPE samples
but not for fresh cells. Incubation at 37 °C may also in-
duce some degree of decross-link to allow DNase I ac-
cessibility to regions of genome. Consistently, our result
showed that a majority of chromatin is larger than 1 kb
and a small fraction of DNA fragments around 50–100
bp is observed at 37 °C incubation (Fig. 1c). These obser-
vations indicate that controlled heat treatment of the
FFPE sample may reduce the extent of cross-linking and
render chromatin fragmentation and extraction more ef-
fective in downstream processing. As typically done in
cell line and frozen tissue, chromatin fragmentation and
extraction in Chrom-EX PE technology can be done by
MNase, sonication, or combined MNase and sonication
depending on the purpose of downstream experiment.
These suggest that some degree of cross-link reversal by
heat treatment may be a way to overcome the heavily
cross-linked nature of FFPE samples. Further investigation
is required to understand the close relationship between
decross-linking kinetics and recovery of chromatin
Table 2 Peak numbers and overlap rate of peaks from FFPE and frozen tissue pairs
Mark Total Peaks in Frozen Total Peaks in FFPE1 % Overlap
m_liver H3K27ac 113,364 128,624 71.08%
m_liver H3K4me3 49,441 56,688 61.24%
m_liver H3K27me3 30,193 19,765 82.21%
m_spleen H3K27ac 98,641 71,648 82.40%
m_spleen H3K4me3 52,991 33,512 94.93%
m_spleen H3K27me3 38,955 13,332 85.85%
m_liver Pol II 10,843 12,825 83.65%
m_liver Pol II 7874 16,421 92.01%
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structure in different incubation conditions. We believe
Chrom-EX PE technology will provide an opportunity to
improve the existing epigenetic technologies and more de-
sirable outcomes for heavily cross-linked FFPE samples.
Conclusions
This study provided a new Chrom-EX PE technology that
achieves efficient extraction of high-quality chromatin
from FFPE tissues. The chromatin generated by this tech-
nology shows a gradual fragmentation pattern dependent
on temperature. We determined that the chromatin gen-
erated at 65 °C is compatible with ChIP assay in targeted
and genome-wide approaches. Importantly, the chromatin
generated at other temperatures may be suitable for
chromatin-based epigenetic assays including accessibility,
nucleosome positioning, and chromatin-chromatin inter-
action. This new technology will provide a better oppor-




Frozen mouse tissues were collected from healthy mice
under the Mayo Clinic IRCUC A00001233–16. The tis-
sues were excised and divided. One piece from each pair
was flash-frozen in liquid nitrogen and stored at − 80 °C
and the other was fixed in 20-fold excess volume of 10%
neutral phosphate-buffered formalin (Leica Biosystems,
Winnipeg, MB) for 48 h. Fixed tissue was dehydrated
and embedded in paraffin using an automated tissue
processor. FFPE blocks were stored at RT for at least 2
years. These samples were used to establish and
optimize Chrom-EX PE protocol.
Development of Chrom-EX PE, chromatin isolation from
FFPE tissues
Two 20-μm sections from the FFPE blocks derived from
mouse tissues were deparaffinized with xylene substitute
and were rehydrated by progressively increasing percentage
of water (95/5, 70/30, 50/50, 20/80). During the progressive
dehydration with different ethanol concentrations, the tis-
sues were resuspended in 0.5ml of chromatin stabilization
buffer (10mM Tris-HCl, pH 7.5, 10mM NaCl, 10mM
EDTA, 0.5% Triton X-100, 0.1% Sodium deoxycholate, 20%
EtOH, proteinase inhibitor cocktails) and incubated in dif-
ferent temperatures ranging 25 °C to 75 °C overnight. As a
control, the tissues were processed without overnight incu-
bation. After the centrifugation (21,130 x g for 5min), the
supernatant was removed. And 0.25ml of cell lysis buffer
(10mM Tris HCl, pH 7.5, 10mM NaCl, 0.5% IGEPAL) was
added and incubated on ice for 10min. The lysates were
washed with MNase digestion buffer (20mM Tris-HCl,
pH 7.5, 15mM NaCl, 60mM KCl, 1mM CaCl2) and were
incubated in the fresh 150 μL MNase digestion buffer
containing proteinase inhibitor cocktails in the presence of
10 gel units of MNase (NEB, Cat.# M0247S) at 37 °C for
20min with continuous mixing in thermal mixer. After
adding the same volume of sonication buffer (100mM
Tris-HCl, pH 8.1, 20mM EDTA, 200mM NaCl, 2% Triton
X-100, 0.2% sodium deoxycholate), the lysates were soni-
cated for 15min (30 s on / 30 s off) using Bioruptor Twin
(UCD-400) (Diagenode, Inc., Denville, NJ) and centrifuged
at 21,130 x g for 10min. The supernatant was transferred
in a new tube. The pellet was resuspended in 100 ul of 1X
FFPE Stop buffer 1 (50mM Tris-HCl, pH 8.1, 10mM
EDTA, 100mM NaCl, 1% Triton X-100, 0.1% Sodium
deoxycholate, 0.05% SDS) and was subjected to sonication
for 15min (30 s on / 30 s off), and centrifuged at 21,130 x g
for 10min. The supernatant was collected into the previ-
ously saved fraction. The pellet was resuspended in 100 ul
of 1X FFPE Stop buffer 2 (50mM Tris-HCl, pH 8.1, 10mM
EDTA, 100mM NaCl, 1% Triton X-100, 0.1% Sodium
deoxycholate, 0.1% SDS) and was subjected to sonication
for 15min (30 s on / 30 s off), and centrifuged at 21,130 x g
for 10min. The supernatant was collected into the previ-
ously saved fraction and the combined soluble fraction was
served as soluble chromatin. The equal volume of soluble
chromatin was mixed with 2X ChIP elution buffer (20mM
Tris-HCl, pH 8.0, 20mM EDTA, 300mM NaCl, 10mM
DTT, 2% SDS) and incubated at 65 °C overnight. The pellet
was resuspended in 1X ChIP elution buffer and incubated
at 65 °C overnight. DNAs were purified using Min-Elute
PCR purification kit after the treatment of RNase A and
proteinase K. DNA amount was measured by the Qubit
dsDNA High Sensitivity assay (Invitrogen, Q32851), and
DNA size was analyzed by the Fragment Analyzer (Ad-
vanced Analytical Technologies; AATI; Ankeny, IA) using
the High Sensitivity NGS Fragment Analysis Kit (Cat.
#DNF-486). For the comparison of soluble chromatin yield,
the ChIP-IT® FFPE Chromatin Preparation Kit (Active
Motif, Cat # 53030) was utilized according to the manufac-
ture’s instructions.
Determination of chromatin yield from mouse FFPE
tissues
The tissue image in FFPE block was captured every 5
cut, and the surface area of tissue was calculated by the
NIH Image J program to determine the tissue size in the
cuts. Two 20-μm sections were deparaffinized with xy-
lene substitute and were rehydrated by progressively in-
creasing percentage of water in ethanol up to 20%. The
tissues were resuspended in 0.5 ml of chromatin
stabilization buffer and incubated at 65 °C overnight.
The tissues were processed as described above. Purified
DNA was measured by the Qubit assay. The chromatin
amount from each FFPE tissue is calculated by DNA
amount per tissue size.
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ChIP-seq
Frozen tissues (25 mg) were homogenized for 30 s in
PBS using tissue grinder (ACTGene, ACT-AG 3080).
Homogenized tissues were cross-linked to final 1% for-
maldehyde, quenched with 125 mM glycine, and washed
with TBS. The fixed homogenates were resuspended in
cell lysis buffer and incubated on ice for 10 min. The ly-
sates were washed with MNase digestion buffer and
were incubated in the fresh 500 μL MNase digestion buf-
fer containing proteinase inhibitor cocktails in the pres-
ence of 1000 gel units of MNase at 37 °C for 20 min
with continuous mixing in thermal mixer. After adding
the same volume of sonication buffer, the lysates were
sonicated for 15 min (30 s on / 30 s off ) using Bioruptor
Twin and centrifuged at 21,130 x g for 10 min. The su-
pernatants were served as chromatin input. For FFPE
tissues, chromatin input was prepared from two 20-μm
sections as described in the development of Chrom-EX
PE. The chromatin input was incubated with
anti-H3K4me3 (abcam ab8580, lot GR188707–1), anti-
RNA pol II antibodies (Bethyl A300–653, lot 3),
anti-H3K27Ac (CST 8173 BC) or anti-H3K27me3 (CST,
9733 s, lot 8) overnight. After adding 10–30 μL of pro-
tein G-magnetic beads, the reactions were further incu-
bated for 3 h. The beads were extensively washed with
ChIP buffer (50 mM Tris-HCl, pH 8.1, 10 mM EDTA,
100 mM NaCl, 1% Triton X-100, 0.1% sodium deoxycho-
late), high salt buffer (50 mM Tris-HCl, pH 8.1, 10 mM
EDTA, 500 mM NaCl, 1% Triton X-100, 0.1% sodium
deoxycholate), LiCl2 buffer (10 mM Tris-HCl, pH 8.0,
0.25M LiCl2, 0.5% NP-40, 0.5% Sodium deoxycholate, 1
mM EDTA), and TE buffer. Bound chromatins were
eluted and reverse-crosslinked at 65 °C overnight. DNAs
were purified using Min-Elute PCR purification kit after
the treatment of RNase A and proteinase K. ChIP en-
richment was validated by performing qPCR in the gen-
omic loci targeting the transcription start sites of an
active or inactive gene and an intergenic region.
ChIP-seq libraries were prepared using the Ovation ul-
tralow DR Multiplex kit (NuGEN, San Carlos, CA) or
the ThruPLEX® DNA-seq Kit V2 (Rubicon Genomics,
Ann Arbor, MI) according to the manufacture’s instruc-
tions. The ChIP-seq libraries were sequenced to 51 base
pairs from both ends on an Illumina HiSeq 2000 instru-
ment in the Mayo Clinic Center for Individualized Medi-
cine Medical Genomics Facility.
Real-time PCR analysis
Real-time PCR analysis was performed using SYBR
Green universal PCR mixes (Bio-Rad). The following
primer sequences were used in the experiments:
H3K4me3- and RNA pol II-positive control locus:
mGAPDH-F: 5′- CTCATCCCCGCAAAGGCGGA -3′,
mGAPDH-R: 5′- TCGGACCTGGCGATGGCTCG-3′.
H3K27me3-positive control locus: mT1-F: 5′- GAGA
CGCCGATCCGCCGAAG -3′, mT1-R: 5′- ACTC
TCCACTCCCACGCGCT-3′. H3K4me3-, RNA pol II-,
and H3K27me3-negative control locus: mIntergenic-F:
5′-CCTGCTGCCTTGTCTCTCTC -3′, mIntergenic-R:
5′-ATGGCCTAGGGATTCCAGCA -3′.
Mapping and analysis of ChIP-seq data
Raw sequencing reads were processed and analyzed
using the HiChIP pipeline [21] to obtain visualization
files and a list of peaks. Briefly, paired-end reads were
mapped to the mouse reference genome (mm10) by
BWA [23] with default settings, and only pairs with at
least one of the ends being uniquely mapped were
retained for further analysis. Duplicates were removed
using the Picard tool set. (https://broadinstitute.github.
io/picard/). Peaks were called using the MACS2 algo-
rithm and SICER at FDR < 1%. Fragment size was calcu-
lated from properly mapped read pairs. Pearson
correlation analysis was performed by our in-house
scripts where all datasets were randomly downsized to
25 million pairs of reads. In brief, the whole genome was
divided into 5-kb bins for H3K4me3 and H3K27Ac and
100-kb bins for H3K27me3 and RNA Pol II, and the
number of mapped reads in each bin was calculated, in
which genomic regions that have zero or missing values
in all samples are excluded. The read count per bin was
normalized to 25 million mapped reads (at least one end
uniquely mapped and duplicates removed), or to 25 mil-
lion mapped reads from non-peak regions (total - reads
mapped to peak regions). The normalized counts by
logarithm log2 (normalized count + 1) were used for
pairwise correlation analysis with Pearson coefficient.
Here, 1 is a pseudo-count to avoid an undefined error of
logarithm of zero. We also profiled the average signal
levels across peak center +/− 2 kb (H3K4me3 and
H3K27Ac) and peak region +/− 2 kb (H3K27me3 and
RNAPII) using ngs.plot [24]. For each pair of samples,
peaks from the two peak lists were first merged if they
were within 1 bp (H3K4me3 and H3K27Ac) or 200 bp of
each other (H3K27me3 and RNAPII). For each merged
peak, a single original peak with the lowest FDR was se-
lected as the representative and used in the plot.
Additional files
Additional file 1: The yield of soluble chromatin is increased in the range
of tested temperatures (25 °C -65 °C). Two 20-μm sections from mouse liver
FFPE tissues were processed by Chrom-EX PE at indicated temperatures. To
accurately measure the impacts of incubation temperature on chromatin
yield, we isolated the chromatin by sonication but no MNase treatment after
tissue-level cross-linking reversal. DNAs were purified from soluble fraction
and insoluble pellet fraction and were quantified using Qubit dsDNA High
Sensitivity assay. The percentage of soluble chromatin was calculated from
two independent experiments. (PDF 50 kb)
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Additional file 2: The genomic location of primer pair along with the
peak profiles of H3K4me3 and H3K27me3 marks are visualized for ChIP-
seq data generated from frozen and FFPE liver tissues in the Integrative
Genomics Viewer. The arrow below the RefGene track indicates the
location of primer pair used in the study. The peak profiles indicate the
antibodies for H3K4me3 and H3K27me3 marks are specific. (PDF 49 kb)
Additional file 3: DNA profiles for chromatin inputs from 4 liver FFPE
tissues relative to Fig. 2a. Two 20-μm sections from mouse liver FFPE
tissues were processed by Chrom-EX PE at 65 °C condition. 2.5% input
were decross-linked and purified by MinElute PCR Purification Kit and
eluted in 16 μl TE and 2 μl DNAs were analyzed by the Fragment
Analyzer. (PDF 31 kb)
Additional file 4: DNA profiles in RNAP II, H3K27Ac, H3K4me3 and
H3K27me3 ChIP-seq libraries from mouse liver FFPE and frozen tissues.
Lane 1, 2: RNAP II libraries from FFPE and frozen tissues; Lane 3–5: H3K27Ac,
H3K4me3 and H3K27me3 libraries from FFPE tissues; Lane 6–8: H3K27Ac,
H3K4me3 and H3K27me3 libraries from frozen tissues. (PDF 38 kb)
Additional file 5: The overall enrichment of three histone marks and
RNA pol II is compared from dataset generated from frozen and FFPE
liver samples. The average signal levels of H3K4me3 and H3K27Ac are
shown across peak center at the upstream and downstream 2 kb. And
the average signal levels of H3K27me3 and RNA Pol II are shown across
peak region at the upstream and downstream 2 kb. (PDF 64 kb)
Additional file 6: Summary of mapping results from the libraries
generated from frozen and FFPE tissues. (PDF 54 kb)
Additional file 7: Replicates overlapping in mouse frozen liver tissues.
(PDF 35 kb)
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